Corvus Pharmaceuticals
CRVS
#5627
Rank
S$1.51 B
Marketcap
S$18.05
Share price
-0.43%
Change (1 day)
299.94%
Change (1 year)

Corvus Pharmaceuticals (CRVS) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : S$12.77 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's total liabilities are S$12.77 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corvus Pharmaceuticals - Total liabilities on balance sheet (from 2015 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$12.72 M-74.23%
2024-12-31S$49.39 M444.48%
2023-12-31S$9.07 M-44.19%
2022-12-31S$16.25 M-2.19%
2021-12-31S$16.61 M-6.12%
2020-12-31S$17.7 M4.75%
2019-12-31S$16.89 M56.66%
2018-12-31S$10.78 M-18.86%
2017-12-31S$13.29 M25%
2016-12-31S$10.63 M-94.2%
2015-12-31S$0.18 B993.14%
2014-12-31S$16.76 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
S$31.6 M 147.41%๐Ÿ‡บ๐Ÿ‡ธ USA